Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
vactosertib (TEW-7197)
i
Other names:
NOV1301, EW-7197, EW 7197, EW7197, NOV 1301, NOV-1301, TEW-7197, TEW7197, TEW 7197
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Ewha Womans University, National OncoVenture, Theragen Etex
Drug class:
TGF-β RI kinase inhibitor
Related drugs:
‹
LY2109761 (2)
ASKC852 (0)
GFH018 (0)
LY3200882 (0)
TP-6379 (0)
LY2109761 (2)
ASKC852 (0)
GFH018 (0)
LY3200882 (0)
TP-6379 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
PD-L1 expression
Non Small Cell Lung Cancer
PD-L1 expression
Non Small Cell Lung Cancer
durvalumab + TEW-7197
Sensitive: C2 – Inclusion Criteria
durvalumab + TEW-7197
Sensitive
:
C2
durvalumab + TEW-7197
Sensitive: C2 – Inclusion Criteria
durvalumab + TEW-7197
Sensitive
:
C2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login